Found: 5
Select item for more details and to access through your institution.
Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases.
- Published in:
- Autoimmune Diseases (2090-0422), 2011, p. 1, doi. 10.4061/2011/945861
- By:
- Publication type:
- Article
Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?
- Published in:
- Crohn's & Colitis 360, 2023, v. 5, n. 4, p. 1, doi. 10.1093/crocol/otad040
- By:
- Publication type:
- Article
Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 9, p. 1347, doi. 10.1093/ecco-jcc/jjac048
- By:
- Publication type:
- Article
Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2016, v. 10, n. 11, p. 1273, doi. 10.1093/ecco-jcc/jjw085
- By:
- Publication type:
- Article
Quantification of pentane in exhaled breath, a potential biomarker of bowel disease, using selected ion flow tube mass spectrometry.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2013, v. 27, n. 17, p. 1983, doi. 10.1002/rcm.6660
- By:
- Publication type:
- Article